Sarah Carter

Sarah Carter is Neumora’s Senior Vice President of Clinical Operations, overseeing operational excellence and global strategic direction for the Company’s clinical stage programs. Previously, she served as Vice President of Business Operations at Oncovalent Therapeutics from 2020 to 2023, responsible for all aspects of business operations and driving key assets to successful IND applications. Ms. Carter has held key leadership roles as Vice President of Business Operations at New Gene Therapy Company and was Head of Global Study Operations at Amgen.  During her time at Amgen between 2001 and 2018, Sarah held roles of increasing responsibility across all disciplines in the clinical trial continuum. Sarah holds a B.S.c in Biomedical Sciences and Chemistry from De Montfort University and an M.S. in Clinical Research from the University of Wales.